Published in

Springer Nature [academic journals on nature.com], Leukemia, 12(30), p. 2397-2401, 2016

DOI: 10.1038/leu.2016.221

Links

Tools

Export citation

Search in Google Scholar

Anti-CD44 antibodies inhibit both mTORC1 and mTORC2: a new rationale supporting CD44-induced AML differentiation therapy

Journal article published in 2016 by Samah Z. Gadhoum, N. Y. Madhoun, A. F. Abuelela ORCID, Jasmeen S. Merzaban
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO